Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FKBP prolyl isomerase 4 pseudogene 8 (FKBP4P8) is classified as a pseudogene derived from the parent gene FKBP4, which encodes an immunophilin (a prolyl isomerase with chaperone activity). Pseudogenes like FKBP4P8 resemble known protein-coding genes but are generally non-functional, lacking evidence for expression or protein product, and are not considered therapeutic targets. There is no evidence for biological function, involvement in disease, or interaction with drugs for FKBP4P8. FKBP4P8 is marked clearly as a pseudogene in curated genomic databases, such as the HUGO Gene Nomenclature Committee (HGNC), Alliance of Genome Resources, and GeneCards. As a pseudogene, FKBP4P8 is predicted to be non-coding and does not produce a functional protein product. There are no publications or functional studies indicating a therapeutic role, disease association, biological activity, or drug interactions for FKBP4P8. The parent gene, FKBP4 (also known as FKBP52), encodes a functionally important immunophilin, but FKBP4P8 itself does not share the protein-coding or target characteristics of FKBP4. FKBP4P8 is frequently listed alongside other FKBP family pseudogenes and is not the functional FKBP4 target. There is no evidence for protein expression, biological function, or therapeutic targeting for this genomic entry, so it should not be considered a druggable or biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FKBP prolyl isomerase 4 pseudogene 8 (FKBP4P8).